DE60004027D1 - Organische-arsenverbindungen - Google Patents

Organische-arsenverbindungen

Info

Publication number
DE60004027D1
DE60004027D1 DE60004027T DE60004027T DE60004027D1 DE 60004027 D1 DE60004027 D1 DE 60004027D1 DE 60004027 T DE60004027 T DE 60004027T DE 60004027 T DE60004027 T DE 60004027T DE 60004027 D1 DE60004027 D1 DE 60004027D1
Authority
DE
Germany
Prior art keywords
arsenic compounds
organic
cancer cells
cells
regard
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60004027T
Other languages
English (en)
Other versions
DE60004027T2 (de
Inventor
M Uckun
Xing-Ping Liu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Parker Hughes Institute
Original Assignee
Parker Hughes Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Parker Hughes Institute filed Critical Parker Hughes Institute
Application granted granted Critical
Publication of DE60004027D1 publication Critical patent/DE60004027D1/de
Publication of DE60004027T2 publication Critical patent/DE60004027T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/66—Arsenic compounds
    • C07F9/70—Organo-arsenic compounds
    • C07F9/80—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
DE60004027T 1999-03-19 2000-03-16 Organische-arsenverbindungen Expired - Fee Related DE60004027T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US12533799P 1999-03-19 1999-03-19
US125337P 1999-03-19
US09/338,680 US6191123B1 (en) 1999-03-19 1999-06-23 Organic-arsenic compounds
US338680 1999-06-23
PCT/US2000/007063 WO2000056742A1 (en) 1999-03-19 2000-03-16 Organic-arsenic compounds

Publications (2)

Publication Number Publication Date
DE60004027D1 true DE60004027D1 (de) 2003-08-28
DE60004027T2 DE60004027T2 (de) 2004-04-22

Family

ID=26823484

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60004027T Expired - Fee Related DE60004027T2 (de) 1999-03-19 2000-03-16 Organische-arsenverbindungen

Country Status (8)

Country Link
US (3) US6191123B1 (de)
EP (1) EP1163246B1 (de)
JP (1) JP2002540114A (de)
AT (1) ATE245655T1 (de)
AU (1) AU4013400A (de)
CA (1) CA2365201A1 (de)
DE (1) DE60004027T2 (de)
WO (1) WO2000056742A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6191123B1 (en) * 1999-03-19 2001-02-20 Parker Hughes Institute Organic-arsenic compounds
AUPQ296799A0 (en) 1999-09-20 1999-10-14 Unisearch Limited A cell-membrane impermeable trivalent organoarsenical derivative and use thereof
AUPR379801A0 (en) 2001-03-19 2001-04-12 Unisearch Limited Use of a substantially cell membrane impermeable compound for treating arthritis
AUPR874601A0 (en) * 2001-11-08 2001-11-29 Unisearch Limited Selective targeting of apoptotic cells
GB0128405D0 (en) * 2001-11-27 2002-01-16 Btg Int Ltd Process for fabricating polyolefin sheet
US20030135041A1 (en) * 2002-01-04 2003-07-17 Orchid Chemicals & Pharmaceuticals Limited, India Synthesis of ceftiofur intermediate
WO2003057012A2 (en) * 2002-01-07 2003-07-17 Board Of Regents, The University Of Texas System S-dimethylarsino-thiosuccinic acid s-dimethylarsino-2-thiobenzoic acid s-(dimethylarsino) glutathione as treatments for cancer
US8394422B2 (en) * 2002-04-26 2013-03-12 Centre National De La Recherche Scientifique (Cnrs) Arsenic therapy for autoimmune and/or inflammatory diseases in mice and humans
FR2838965B1 (fr) 2002-04-26 2004-06-25 Centre Nat Rech Scient Therapie par l'arsenic du syndrome autoimmunlymphoproliferatif de type apls chez la souris comme chez l'homme
ES2330519T3 (es) 2002-11-07 2009-12-11 Newsouth Innovations Pty Limited Inducion de la transicion de permeabilidad mitocondrial.
US6686344B1 (en) 2003-01-30 2004-02-03 Paker Hughes Institute Organic-arsonic compounds
TW201440760A (zh) * 2004-07-16 2014-11-01 Texas A & M Univ Sys 有機砷化合物、其用於治療癌症之用途及包含其之醫藥組成物
US7968738B2 (en) 2005-07-29 2011-06-28 Ziopharm Oncology, Inc. Compounds and methods for the treatment of cancer
TW200829261A (en) * 2006-09-29 2008-07-16 Ziopharm Oncology Inc Method for controlling angiogenesis in animals
EP2069371B1 (de) 2006-11-01 2013-03-13 NewSouth Innovations Pty Limited Organo-arsenoxid-verbindungen und deren verwendung
ES2392737T3 (es) * 2007-11-02 2012-12-13 Ziopharm Oncology, Inc. Terapia combinada con compuestos arsenicales orgánicos
BRPI0821002A2 (pt) * 2007-12-12 2015-06-16 Ziopharm Oncology Inc Compostos e métodos para o tratamento de câncer
DK3388111T3 (da) 2008-08-20 2021-12-06 Solasia Pharma K K Organoarsenforbindelse til behandlingen af kræft
EP2379506B1 (de) 2008-12-30 2015-09-02 ArQule, Inc. Substituierte 5,6-dihydro-6-phenylbenzo[f]-isochinolin-2-aminver-bindungen

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3017380A (en) * 1958-12-05 1962-01-16 Dal Mon Research Co Aldehyde-triazinyl arsenic condensation products and method of making same
SU977461A1 (ru) * 1981-04-28 1982-11-30 Ордена Ленина Институт Геохимии И Аналитической Химии Им.В.И.Вернадского Способ получени 2,7-бис-(2-арсонофенилазо)-1,8-диоксинафталин-3,6-дисульфокислоты (арсеназо ш)
FR2640269B1 (fr) * 1988-12-13 1991-03-15 Maes Ludo Composes organometalliques, leurs modes de preparation et compositions pharmaceutiques les contenant
FR2684382B1 (fr) * 1991-12-02 1994-10-21 Rhone Merieux Medicaments et preparations pures de dichlorhydrate de melarsomine, leur procede d'obtention et produits intermediaires obtenus.
DE69529575T2 (de) * 1994-11-30 2003-08-21 Univ Hospital Boston Arzneimittel zur behandlung von parasitischen und pilzartigen infektionen
US6191123B1 (en) * 1999-03-19 2001-02-20 Parker Hughes Institute Organic-arsenic compounds

Also Published As

Publication number Publication date
EP1163246B1 (de) 2003-07-23
ATE245655T1 (de) 2003-08-15
DE60004027T2 (de) 2004-04-22
AU4013400A (en) 2000-10-09
CA2365201A1 (en) 2000-09-28
EP1163246A1 (de) 2001-12-19
US6482815B1 (en) 2002-11-19
WO2000056742A9 (en) 2001-11-01
US6191123B1 (en) 2001-02-20
JP2002540114A (ja) 2002-11-26
US6482816B1 (en) 2002-11-19
WO2000056742A1 (en) 2000-09-28

Similar Documents

Publication Publication Date Title
DE60004027D1 (de) Organische-arsenverbindungen
TW200616615A (en) Compounds and methods for the treatment of cancer
YU52099A (sh) Fungicidni trifluormetilalkilamino-triazolpirimidini
PT1318992E (pt) Derivados do imidazole como inibidores da cinase raf
ECSP055863A (es) Piridodiacinas como funguicidas de plantas
GT199900070A (es) Derivados de isotiazol, utiles como agentes anticancerosos.
BR0210471A (pt) Ligandos do receptor 5-ht e suas utilizações
DK1200412T3 (da) Antiproliferative imidazolforbindelser
GB0119249D0 (en) Organic compounds
AR022860A1 (es) Derivados de camptotecina que poseen actividad antitumoral
HK1088845A1 (en) Use of parthenolide derivatives as antileukemic and cytotoxic agents
BRPI0415525A (pt) derivados de imidazola e seu uso como agentes farmacêuticos
ZA200502790B (en) Extract with anti-tumor and anti-poisonous activity.
WO2007027344A3 (en) Compounds and methods for the treatment of cancer
HK1040983A1 (en) Quinones for treatment of diseases.
UA29466C2 (uk) Фармацевтична композиція з антипухлинною активністю
ATE299505T1 (de) Fungizide 6-(2-halo-4-alkoxyphenyl)- triazolopyrimidine
ATE327973T1 (de) Polyamin-analoge als cytotoxische wirkstoffe
DE602005027739D1 (de) Arylsubstituiertes benzimidazol- und imidazopyridinether als wirkstoffe gegen krebs
DE60100855D1 (de) 1,8-naphthalimid imidazo[4,5,1-de]acridone mit antitumorwirkung
ES2159488B1 (es) Procedimiento para la preparacion de derivados de pirimidona con actividad antifungica.
BRPI0507811A (pt) derivados de 7h-pirrolopirimidina
DK1142905T3 (da) Hidtil ukendt depsipeptidforbindelse
AR021694A1 (es) Retinamidas de acido 7-aril-6-(z)heptatrienoico
AR023979A1 (es) Procesos para preparar compuestos intermedios de plaguicidas

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee